MAPT Antikörper (N-Term)
Kurzübersicht für MAPT Antikörper (N-Term) (ABIN603846)
Target
Alle MAPT Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Recognizes N-terminus region of human Tau.
-
Aufreinigung
- Protein G purified
-
Immunogen
-
KLH conjugated synthetic linear peptide.
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
-
Approved: WB (1 μg/mL)
Usage: Suitable for use in Western blot: 1 μg/mL. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 0.1 M Tris-glycine, pH 7.4, 150 mM sodium chloride, 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- May be stored at 4°C for short-term only. For long-term storage and to avoid freeze-thaw cycles, aliquot and store at -20°C. Aliquots are stable for at least 1 year at -20°C.
-
-
- MAPT (Microtubule-Associated Protein tau (MAPT))
-
Andere Bezeichnung
- MAPT / tau
-
Hintergrund
-
Name/Gene ID: MAPT
Synonyms: MAPT, FTDP-17, MSTD, Neurofibrillary tangle protein, PHF-tau, MTBT2, PPND, DDPAC, MAPTL, MTBT1, Paired helical filament-tau, TAU -
Gen-ID
- 4137
-
Pathways
- MAPK Signalweg, Microtubule Dynamics, M Phase, Regulation of Cell Size
Target
-